Author | Year | Flow Diverter | No. of Patients | Thromboembolic Complications | Hemorrhagic Complications | Median Follow-Up Time (mo) |
---|---|---|---|---|---|---|
Möhlenbruch et al8 | 2015 | FRED | 29 | 14.0% | 3.0% | 6 |
Poncyljusz et al11 | 2013 | FRED | 6 | 17.0% | 0.0% | 3 |
Briganti et al12 | 2016 | FRED | 20 | 0.0% | 0.0% | 12 |
Lubicz et al13 | 2015 | Silk | 26 | 23.1% | 11.5% | 6 |
Briganti et al4 | 2012 | Silk + Pipeline | 273 | 4.8% | 5.5% | 3 |
Colby et al7 | 2016 | Pipeline Flex | 44 | 2.0% | 0.0% | Not applicable |
De Vries et al14 | 2013 | Surpass | 37 | 13.5% | 5.4% | 12 |
Fischer et al15 | 2015 | p64 | 130 | 3.0% | 0.0% | 9 |
Our data | 2016 | FRED | 48 | 15.4% | 1.9% | 12 |